Antibiotics Rule In Greece Attacked

10 March 1997

Greek pharmacists, doctors and health fund enrollees have deplored theMinistry of Employment and Social Security's statement that third-generation antibiotics may only be prescribed through state health insurance funds following an "antibiogram." They say that it takes three days to obtain the test results, during which time a patient's condition can deteriorate, and that not all towns have facilities for the tests.

The Deputy Minister for Employment and Social Security, Mr Farmakis, denies that the funds are trying to save money by depriving insured people of drugs. He says the aim is to protect public health, as uncontrolled use of certain antibiotics can be dangerous. Greeks consume more antibiotics per head than other Europeans, with spending in 1995 of 92 billion drachmas ($355.9 million), and infections are becoming resistant to antibiotics.

He also says many people profit out of Greece's 500 billion-drachma drug market, so there will be reactions against moves to curb unnecessary consumption. The Marketletter's local correspondent says this figure is probably exaggerated, given informal industry estimates of about 300 billion drachmas for 1996. The real figure probably lies between the two.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight